Sponsor:
Children's Hospital of Philadelphia
Code:
NCT06892158
Conditions
Cancer
Pediatric Cancer
Chemotherapy Effect
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia, Pediatric
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Interventions
Massage therapy
Standard of care
Brief summary:
Conditions
Cancer
Pediatric Cancer
Chemotherapy Effect
Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia, Pediatric
Study ID
NCT06892158
Start date
Jan 23, 2025
Status verified date
Apr, 2026
Completion date
Jul, 2028
Anticipated
Primary completion date
Jan, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Enrollment
70 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Control Arm (CA)
experimental: Intervention Arm (IA)
Interventions
Massage therapy
Standard of care
Primary outcome measure
Central contacts
Locations
Children's Hospital of Philadelphia
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Tracey Jubelirer, MD
jubelirer@chop.eduLauren Vernau
vernaul@chop.eduSponsor
Children's Hospital of Philadelphia
Last update posted
Apr 15, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2026-04-15.